Monodisperse nanoparticles from self-assembling amphiphilic cyclodextrins: Modulable tools for the encapsulation and controlled release of pharmaceuticals

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 524-532

  Mendez Ardoy, Alejandro ^a   Gómez García, Marta ^a   Gèze, Annabelle ^b   Putaux, Jean Luc ^c   Wouessidjewe, Denis ^b   Mellet, Carmen Ortiz ^a   Defaye, Jacques ^b   Fernández, José M García ^d   Benito, Juan M ^d  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIV GRENOBLE ALPES   (France)

^c CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

^d INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

Author keywords

Controlled drug release; Cyclodextrins; Drug delivery; Facial amphiphiles; Nanocapsules; Nanoparticles; Nanospheres; Self assembly

Indexed keywords

CYCLODEXTRIN DERIVATIVE; DIAZEPAM; FUNCTIONAL GROUP; HYDROXYL GROUP; NANOCAPSULE; NANOPARTICLE; NANOSPHERE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SYNTHESIS; NANOENCAPSULATION; PRIORITY JOURNAL; SUSPENSION; ZETA POTENTIAL;

CAPSULES; CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; DIAZEPAM; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NANOPARTICLES; PARTICLE SIZE; SUSPENSIONS;

EID: 84863756394     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216265     Document Type: Article

References (46)

1. For a complete survey on CD molecular inclusion properties, see: Dodziuk, H. Ed. Cyclodextrins and Their Complexes; Wiley-VCH: Weinheim, 2006.
2. Loftsson, T.; Duchêne, D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm., 2007, 329, 1-11.
3. Davis, M. E.; Brewster, M. E. Cyclodextrin-based pharmaceutics: Past, present and future. Nat. Rev. Drug. Discov., 2004, 3, 1023-1035.
4. Li, J.; Loh, X. J. Cyclodextrin-based supramolecular architectures: Syntheses, structures, and applications for drug and gene delivery. Adv. Drug Deliv. Rev., 2008, 60, 1000-1017.
5. Defaye, J.; Garcia Fernandez, J. M.; Ortiz Mellet, C. Pharmaceutical use of cyclodextrines: perspectives for drug targeting and control of membrane interactions. Ann. Pharm. Fr., 2007, 65, 33-49.
6. Carrier, R. L.; Miller, L. A.; Ahmed, I. The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Rel., 2007, 123, 78-99.
7. Strickley, R. G. Solubilizing excipients in oral and injectable formulations. Pharm. Res., 2004, 21, 201-230.
8. Martín Del Valle, E. M. Cyclodextrins and their uses: a review. Proc. Biochem., 2004, 39, 1033-1046.
9. Bushmann, H.-J.; Schollmeyer, E. Applications of cyclodextrins in cosmetic products: A review. J. Cosmetic Sci., 2002, 53, 185-191.
10. Szente, L.; Szejtli, J. Cyclodextrins as food ingredients. Trends Food Sci. Technol., 2004, 15, 137-142.
11. Astray, G.; González-Barreiro, C.; Mejuto, J. C.; Rial-Otero, R.; Simal-Gándar, J. A review on the use of cyclodextrins in foods. Food Hydrocol., 2009, 23, 1631-1640.
12. Rekharsky, M. V.; Inoue, Y. Complexation thermodynamics of cyclodextrins. Chem. Rev., 1998, 98, 1875-1918.
13. Loftsson, T.; Hreinsdóttir, D.; Másson, M. The complexation efficiency. J. Incl. Phenom. Macrocycl. Chem., 2007, 57, 545-552.
14. Clark, J. K.; van Egmond, J.; Feilden, H.; MacLean, E. J.; Muir, A. W.; Palin, R.; Rees, D. C.; Zhang, M.-Q. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew. Chem. Int. Ed., 2002, 41, 266-270.
15. Van De Manakker, F.; Vermonden, T.; van Nostrum, C. F.; Hennink, W. E. Cyclodextrin-based polymeric materials: Synthesis, properties, and pharmaceutical/biomedical applications. Biomacromolecules, 2009, 10, 3157-3174.
16. Sallas, F.; Darcy, R. Amphiphilic cyclodextrins - Advances in synthesis and supramolecular chemistry. Eur. J. Org. Chem., 2008, 957-969.
17. Bilensoy, E.; Hincal, A. A. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opin. Drug Deliv., 2009, 6, 1-13.
18. Parrot-Lopez, H.; Perret, F.; Bertino-Ghera, B. Les cyclodextrines amphiphiles et leurs applications. Élaboration de nanoparticules de cyclodextrines amphiphiles pour des applications biomédicales. Ann. Pharm. Fr., 2010, 68, 12-26.
19. Ravoo, B. J.; Darcy, R. Cyclodextrin bilayer vesicles. Angew. Chem. Int. Ed., 2000, 39, 4324-4326.
20. Choisnard, L.; Gèze, A.; Putaux, J.-L.; Wong, Y.-S.; Wouessidjewe, D. Nanoparticles of β-cyclodextrin esters obtained by self-assembling of biotransesterified β-cyclodextrins. Biomacromolecules, 2006, 7, 515-520.
21. Mazzaglia, A.; Donohue, R.; Ravoo, B. J.; Darcy, R. Novel amphiphilic cyclodextrins: Graft-synthesis of heptakis (6-alkylthio-6-deoxy)-β- cyclodextrin 2-oligo (ethylene glycol) conjugates and their omega-halo derivatives. Eur. J. Chem., 2001, 1715-1721.
22. Ling, C.-C.; Darcy, R.; Risse, W. Cyclodextrin liquid crystals: synthesis and self-organisation of amphiphilic thio-β-cyclodextrins. J. Chem. Soc. Chem. Commun., 1993, 438-440.
23. Kawabata, Y.; Matsumoto, M.; Tanaka, M.; Takahashi, H.; Irinatsu, Y.; Tamara, S.; Tagaki, W.; Nakahara, H.; Fukuda, K. Formation and deposition of monolayers of amphiphilic β-cyclodextrin derivatives. Chem. Lett., 1986, 11, 1933-1934.
24. Benito, J. M.; Ortiz Mellet, C.; García Fernández, J. M. Cyclodextrins in gene delivery. Chem. Soc. Rev., 2011, 40, 1586-1608.
25. Ortiz Mellet, C.; Benito, J. M.; García Fernández, J. M. Preorganized macromolecular gene delivery systems. Chem. Eur. J., 2010, 16, 6728-6742.
26. Vargas-Berenguel, A.; Ortega-Caballero, F.; Casas-Solva, J. M. Supramolecular chemistry of carbohydrate clusters with cores having guest binding abilities. Mini-Rev. Org. Chem., 2007, 4, 1-14.
27. Strickland, A. D.; Batt, C. A. Detection of carbendazim by surfaceenhanced Raman scattering using cyclodextrin inclusion complexes on gold nanorods. Anal. Chem., 2009, 81, 2895-2903.
28. Villalonga, R.; Cao, R.; Fragoso, A. Supramolecular chemistry of cyclodextrins in enzyme technology. Chem. Rev., 2007, 107, 3088-3116.
29. Dubes, A.; Bouchu, D.; Lamartine, R.; Parrot-Lopez, H. Tetrahedron Lett., 2001, 42, 9147-9151.
30. Lesieur, S.; Charon, D.; Lesieur, P.; Ringard-Lefebvre, C.; Muguet, V.; Duchêne, D.; Wouessidjewe, D. Phase behavior of fully hydrated DMPC-amphiphilic cyclodextrin systems. Chem. Phys. Lipids, 2000, 106, 127-144.
31. Díaz-Moscoso, A.; Balbuena, P.; Gómez-García, M.; Ortiz Mellet, C.; Benito, J. M.; Le Gourriérec, L.; Di Giorgio, C.; Vierling, P.; Mazzaglia, A.; Micali, N.; Defaye, J.; García Fernández, J. M. Rational design of cationic cyclooligosaccharides as efficient gene delivery systems. Chem. Commun., 2008, 2001-2003.
32. Díaz-Moscoso, A.; Le Gourriérec, L.; Gómez- García, M.; Benito, J. M.; Balbuena, P.; Ortega-Caballero, F.; Guilloteau, N.; Di Giorgio, C.; Vierling, P.; Defaye, J.; Ortiz Mellet, C.; García Fernández, J. M. Polycationic amphiphilic cyclodextrins for gene delivery: Synthesis and effect of structural modifications on plasmid DNA complex stability, cytotoxicity, and gene expression. Chem. Eur. J., 2009, 15, 12871-12888.
33. Gadelle, A.; Defaye, J. Selective halogenation at primary positions of cyclomaltooligosaccharides and a synthesis of per-3, 6-anhydro cyclomaltooligosaccharides. Angew. Chem. Int. Ed., 1991, 31, 78-80.
34. Skiba, M.; Wouessidjewe, D.; Puisieux, F.; Duchêne, D.; Gulik, A. Characterization of amphiphilic β-cyclodextrin nanospheres. Int. J. Pharm., 1996, 142, 121-124.
35. Fessi, H. C.; Devissaguet, J.-P.; Puisieux, F.; Thies, C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. U. S. Patent 5, 118, 528, June 2, 1992.
36. Gèze, A.; Putaux, J.-L.; Choisnard, L.; Jehan, P.; Wouessidjewe, D. Long-term shelf stability of amphiphilic β-cyclodextrin nanosphere suspensions monitored by dynamic light scattering and cryotransmission electron microscopy. J. Microencapsul., 2004, 21, 607-613.
37. The use of conventional acylation conditions (e.g. acyl chlorides and/or nucleophilic catalysts such as triethylamine) furnishes either partial halogen displacement or underacylated adducts that severely hampers purification of uniformly functionalized compounds. See for instance: Zhang, Z.; Ling, C.-C.; Coleman, A. W.; Parrot-Lopez, H.; Galons, H. Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face. Tetrahedron Lett., 1991, 32, 2769-2770.
38. Méndez-Ardoy, A.; Gómez-García, M.; Ortiz Mellet, C.; Sevillano, N.; Girón, M. D.; Salto, R.; Santoyo-González, F.; García Fernández, J. M. Preorganized macromolecular gene delivery systems: amphiphilic β-cyclodextrin "click clusters". Org. Biomol. Chem., 2009, 7, 2681-2684.
39. García Fernández, J. M.; Ortiz Mellet, C. Chemistry and developments of N-thiocarbonyl carbohydrate derivatives: Sugar isothiocyanates, thioamides, thioureas, thiocarbamates, and their conjugates. Adv. Carbohydr. Chem. Biochem., 2000, 55, 35-135.
40. Joshi, M. D.; Müller, R. H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm., 2009, 71, 161-172.
41. Sznitowska, M.; Gajewska, M.; Janicki, S.; Radwanska, A.; Lukowski, G. Bioavailability of diazepam from aqueous organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur. J. Pharm. Biopharm., 2001, 51, 159-163.
42. Abdelbary, G.; Fahmy, R. H. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech, 2009, 10, 211-219.
43. Cavalli, R.; Trotta, F.; Trotta, M.; Pastero, L.; Aquinalo, D. Effect of alkylcarbonates of γ-cyclodextrins with different chain lengths on drug complexation and release characteristics Int. J. Pharm., 2007, 339, 197-204.
44. Gèze, A.; Choisnard, L.; Putaux, J.-L.; Wouessidjewe, D. Colloidal systems made of biotransesterified α, β and γ cyclodextrins grafted with C10 alkyl chains. Mater. Sci. Eng. C, 2009, 29, 458-462.
45. Memişoǧlu, E.; Bochot, A.; Özalp, M.; Duchêne, D.; Hincal, A. A. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res., 2002, 20, 117-125.
46. Memişoǧlu-Bilensoy, E.; Şen, M.; Hincal, A. A. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules. J. Microencapsul., 2006, 23, 59-68.